Clinical trial
Umbrella Study for HIV Infected Adults Enrolled in NIAID-Funded Interleukin-2…
NCT00311688 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00311688 |
|---|---|
| Title | Umbrella Study for HIV Infected Adults Enrolled in NIAID-Funded Interleukin-2 Studies |
| Official title | An Omnibus Proleukin (IL-2) Trial in HIV Infected Patients Including Interrupted Versus Continuous Antiretrovirals (OPTICA) |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Study type | Observational [Patient Registry] |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Interleukin-2 |
| Start date | Dec 1, 2003 |
| Primary completion | Dec 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Apr 6, 2006 |
| Last update posted | Nov 1, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: